Universal Health Coverage
IFPMA works in partnership with other members of the global health community to achieve Universal Health Coverage targets and contribute to a world where no one is left behind in receiving the healthcare they need.
Universal Health Coverage (UHC) means that all individuals and communities receive the health services they need without suffering financial hardship.
It covers all essential, quality health services – from health promotion to prevention, treatment, rehabilitation, and palliative care – across the life course. This principle is at the heart of the Sustainable Development Goals (SDGs).
Strengthening health systems
UHC is the cornerstone of global health equity and sustainable development. However, 50% of the world’s population do not have access to the essential health services, indicating that major efforts will be required to overcome this critical gap.
The Covid-19 pandemic has amplified the need for ready and resilient health systems that ensure health for all. The second UN High-level Meeting on UHC scheduled September 2023 sets a global stage to discuss opportunities and challenges for UHC.
IFPMA is committed to progress toward UHC and seeks to leverage innovation to achieve health equity, emphasizing three foundational elements: improving primary health care, ensuring adequate financing, and focusing on multistakeholder partnerships. Read our position paper on UHC.
of the world’s population do not have access to the health care they need
people are driven into poverty each year because of out-of-pocket health spending
cross-sector collaborations involving our members to advance the achievement of SDG 3 and UHC
UHC2030 Private sector engagement
The innovative pharmaceutical industry plays a key role toward achieving UHC.
As a key member of the UHC2030 Private Sector Constituency (PSC), IFPMA is strongly supportive of the recent UHC2030 Private Sector Constituency statement on private sector commitments drawing from the Action Agenda. The Action Agenda is a set of action-oriented policy recommendations aimed at country leaders to strengthen resilient and equitable health systems, advance universal health coverage and health security, and deliver health for all by 2030.
The UHC2030 PSC statement outlined five commitments:
- Incorporate UHC principles, including to leave no one behind, into our business
- Deliver innovations that respond to the needs of all people including underserved populations, and make these safe, affordable, accessible, and sustainable
- Help strengthen the health workforce, responding to local context, priorities and needs
- Contribute to efforts to raise the finance available for UHC
- Champion and engage in multi-stakeholder policy dialogues that advance UHC.
The power of partnerships and innovation: Accelerating progress toward Universal Health Coverage by 2030
In a blog for PharmaBoardroom, Thomas Cueni shares his views on the innovative pharmaceutical industry’s role in bringing critical solutions to accelerate progress toward UHC, from lab to the last mile.
Collaborating to achieve universal health coverage
Explore how the innovative pharmaceutical industry is partnering to ensure innovation and access contribute to global health progress and improve lives everywhere in this report. The Sustainable Development Goals (SDGs) explicitly strive to engage the private sector in addressing the world’s most pressing challenges and emphasize the importance of cross-sector collaborations. Universal Health Coverage (UHC)...
Explore Global Health Progress
Global Health Progress is an interactive knowledge hub highlighting over 250 collaborations in low- and middle-income countries between the innovative pharmaceutical industry and over 1100 diverse partners to support the SDGs.
See how we're supporting African health innovation
We contribute to sustainable local solutions and policies that support greater access to health services and innovations in lower-resources settings, especially in Africa, through partnership and capacity building.
Reinforcing collaboration on UHC to deliver greater global health equity and health security
Building on our 2019 policy perspectives on UHC, the innovative pharmaceutical industry stands together with the global health community to support countries in accelerating their efforts to achieve UHC.